BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10808349)

  • 21. The coxibs, selective inhibitors of cyclooxygenase-2.
    FitzGerald GA; Patrono C
    N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
    [No Abstract]   [Full Text] [Related]  

  • 22. COX-2 inhibitors.
    Crowther CL
    Lippincotts Prim Care Pract; 1999; 3(4):394-6. PubMed ID: 10624270
    [No Abstract]   [Full Text] [Related]  

  • 23. COX-2 inhibitors: no pain, no heart gain?
    Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
    [No Abstract]   [Full Text] [Related]  

  • 24. COX-2-specific inhibition: implications for clinical practice.
    Pascucci RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S18-22. PubMed ID: 10643177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial patterns of use of COX-2 inhibitors by elderly patients in Ontario: findings and implications.
    Mamdani M; Rochon P; Laupacis A; Anderson G
    CMAJ; 2002 Nov; 167(10):1125-6. PubMed ID: 12427703
    [No Abstract]   [Full Text] [Related]  

  • 26. Patent prompts Rochester to sue for slice of drug profits.
    Malakoff D
    Science; 2000 Apr; 288(5465):410-1. PubMed ID: 10798965
    [No Abstract]   [Full Text] [Related]  

  • 27. Celecoxib: a COX-2 inhibitor.
    Andrews SA; Wallace CK; Davis RL
    Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract]   [Full Text] [Related]  

  • 28. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors.
    Stephens J; Laskin B; Pashos C; Peña B; Wong J
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii40-52. PubMed ID: 14585917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
    Atkinson HG
    Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
    Nasonova VA
    Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752
    [No Abstract]   [Full Text] [Related]  

  • 31. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
    Tindall E
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy].
    MMW Fortschr Med; 2003 Jul; 145(29-30):61. PubMed ID: 12958786
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F; Michaud K; Burke TA; Zhao SZ
    J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Specific COX-2 inhibitors. Also effective in arthritis?].
    Einecke D
    MMW Fortschr Med; 2000 Jan; 142(3):10. PubMed ID: 10726454
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
    Hochberg MC
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new pharmacological principle is effective--rofecoxib. Specific COX-2 inhibition].
    MMW Fortschr Med; 1999 Dec; 141(51-52):66-7. PubMed ID: 10949630
    [No Abstract]   [Full Text] [Related]  

  • 38. [Topical pharmacology. COX-2 inhibitors].
    Heinzl S
    Med Monatsschr Pharm; 1999 Oct; 22(10):298-304. PubMed ID: 10540801
    [No Abstract]   [Full Text] [Related]  

  • 39. [Selective cyclooxygenase-2 (COX-2) inhibitors: importance and limitations].
    Pairet M; Netter P
    Therapie; 1999; 54(4):433-45. PubMed ID: 10667110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?].
    Peretz A
    Rev Med Brux; 2001 Sep; 22(4):A377-80. PubMed ID: 11680204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.